ArticleJournal of psychosomatic research2025
Association between depressive symptoms and health status outcomes in patients with symptomatic peripheral artery disease.
Article in Journal of psychosomatic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionDepressive symptoms frequently co-occur in peripheral artery disease (PAD) and are associated with adverse clinical outcomes. We examined the association between depressive symptoms upon PAD presentation and PAD-specific health status outcomes.
methodsPatients with new or worsening claudication in the PORTRAIT registry (2011-2015) were included. Health status was assessed at baseline, 3, 6, and 12 months using the Peripheral Artery Questionnaire (PAQ). Baseline depressive symptoms were measured with the Patient Health Questionnaire (PHQ-8). A mixture repeated measures model was used to estimate health status over time. Interactions between symptoms, sex, and treatment (early invasive vs. non-invasive) were tested in a propensity-matched cohort.
resultsOf 1272 patients, 36.8 % had mild, moderate, or severe depressive symptoms. Baseline mean PAQ summary scores were lower in patients with no vs. severe symptoms (53.06 [95 % CI 48.98, 57.13) vs. 40.30 [95 % CI 33.21, 47.4), p < 0.001). PAQ scores significantly improved within three months across depression severity (+14.3 points [95 % CI 12.0, 16.5] for no vs. +24 [95 % CI 17.0, 30.9] for severe symptoms). PAQ scores stabilized after 3 months (12-month mean 69.64 [95 % CI 65.56, 73.71) for no vs. 67.20 [95 % CI 60.10, 74.29] for severe symptoms, p = 0.105). No interactions between depression severity, sex, or PAD treatment were found.
conclusionPatients with PAD and depressive symptoms have lower baseline health status than those without. Health status improved within three months of vascular specialty care and stabilized afterwards, regardless of depression severity. Further integration of depression management within PAD care is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.